About Us


The programme is based on several different research groups at Karolinska Institutet and Umeå University and was started in 2010 with support from the government in a strategic initiative (the SFO initiative) and with support from KI and Stockholm County Council through the theme center initiative. By forming an integrated research environment in diabetes and metabolism SRP Diabetes has become a Swedish knowledge hub in this area. The programme translates results between clinical and basic science to improve the care and treatment of people with diabetes. SRP Diabetes came out very well in the international evaluation in 2015 (in the top 8 %) and the programme has been prolonged another 5 years until 2020 with support by the government through the SFO initiative.

Organizational Structure. Anna Krook (AK), Juleen Zierath (JRZ), Peter Arner (PA), Per-Olof Berggren (P-O B), Erik Näslund (EN) and Helena Edlund (HE) 


The overall goal of the Strategic Research Programme in Diabetes at Karolinska Institutet is to improve both prevention and treatment of diabetes by forming a strong, integrated research environment in the diabetes field, rich in collaboration, communication, and scientific exchange.

Specifically, the programme aims to:

  • Develop and support common infrastructures such as a Metabolic Phenotyping Centre for Diabetic Animal Models, a Centre for Clinical Metabolic Research in Diabetes, a Beta Cell Imaging Facility and support for Enabling Technologies (genomics and bioinformatics)
  • Increase interactions between the research teams of the programme by supporting collaborative projects and arranging common symposia, meetings and seminars
  • Support PhD education within the research areas connected to the programme
  • Increase translational research by supporting collaborative projects between experimental and clinical researchers
  • Increase international contacts
  • Increase the interaction with the biotech and pharmaceutical industry
  • Support commercial utilization by providing in-house expertise and money for business development by linking to the Karolinska Institutet Innovation system

The programme coordinates laboratories possessing substantial expertise and unique technical resources, thus affording a natural point of contact for collaboration within the diabetes area, both for researchers within Karolinska Institutet and Umeå University as well as with external researchers.

Management Group



Anna Krook

Phone: +46-(0)8-524 878 24
Organizational unit: Krook Anna group - Integrative Physiology
E-mail: Anna.Krook@ki.se


Professor, senior

Peter Arner

Organizational unit: Unit for Endocrinology and Diabetes
E-mail: Peter.Arner@ki.se

Management Group Member


Per-Olof Berggren

Phone: +46-(0)8-517 757 31
Organizational unit: Signal Transduction
Department: Department of Molecular Medicine and Surgery (MMK), K1
E-mail: Per-Olof.Berggren@ki.se

Management Group Member

Professor, Head of UCMM

Helena Edlund

Phone: +46(0)90 785 44 29
E-mail: helena.edlund@ucmm.umu.se
Address: Centre for Molecular Medicine, Umeå University

Management Group Member

Head of department

Erik Näslund

Phone: +46-(0)8-123 550 17
Organizational unit: Ledningsgrupp
E-mail: Erik.Naslund@ki.se

Management Group Member


Juleen Zierath

Phone: +46-(0)8-524 875 80
Organizational unit: Integrative Physiology
E-mail: Juleen.Zierath@ki.se

Programme Manager


Stefan Nobel

Phone: +46-(0)8-524 869 80
Organizational unit: Integrative Physiology
E-mail: stefan.nobel@ki.se

Innovation Officer

Patrik Blomquist



E-mail: patrik.blomquist@kiinnovations.se
Address: Karolinska Institutet Innovations AB

Communications Officer


Barbro Svensson

Phone: +46-(0)8-524 822 61
Organizational unit: Krook Anna group - Integrative Physiology
E-mail: barbro.svensson@ki.se

Scientific Advisory Board

Isadore and Fannie Foxman Professor, Chair

Michael Czech

Address: Program in Molecular Medicine, University of Massachusetts Medical School

Professor Biochemistry, Paediatrics & Physiology

Amira Klip

Address: University of Toronto and Hospital for Sick Children

Professor of Nutrition and Medical Biochemistry

Dominique Langin

Address: Obesity Research Laboratory, Inserm UPS U858

CEO and Director

John Nolan

Address: Steno Diabetes Center A/S, Denmark

Professor of Molecular Diabetology

Michele Solimena

Address: Techn University Dresden